COVID‐19 and hereditary spherocytosis: A recipe for hemolysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

COVID‐19 and hereditary spherocytosis: A recipe for hemolysis

Published:2020-07-25 Issue:1 Volume:68 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Severance Tyler S.¹²³^ORCID,Rahim Mahvish Q.¹²³,French James¹²³,Baker Richelle M.¹²⁴,Shriner Andrew¹²⁴,Khaitan Alka¹²⁵,Overholt Kathleen M.¹²³

Affiliation:

1. Riley Hospital for Children Indianapolis Indiana

2. Indiana University School of Medicine Indianapolis Indiana

3. Riley Hospital Division of Pediatric Hematology Oncology Indianapolis Indiana

4. Riley Hospital Division of Pediatric Hospital Medicine Indianapolis Indiana

5. Riley Hospital Division of Pediatric Infectious Disease Indianapolis Indiana

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28548

Reference18 articles.

1. Old and new insights into the diagnosis of hereditary spherocytosis

2. A de novo band 3 mutation in hereditary spherocytosis

3. A new frameshift mutation of the β-spectrin gene associated with hereditary spherocytosis

4. What does the spleen see?

5. Mechanics of diseased red blood cells in human spleen and consequences for hereditary blood disorders

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transient erythroblastopenia of childhood after COVID-19 infection: a case report;Italian Journal of Pediatrics;2024-07-29

2. Transient erythroblastopenia of childhood after Covid-19 infection: a case report;2024-05-10

3. COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches;Cell Communication and Signaling;2024-02-15

4. Progression of hemolysis in a patient with hereditary spherocytosis after the second dose of COVID-19 mRNA vaccine: Correspondence;Human Vaccines & Immunotherapeutics;2023-11-22

5. COVID-19 and Anemia: What Do We Know So Far?;Hemoglobin;2023-05-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3